Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial Elizabeth Alexander, MD, MSc; Lisa Goldberg, MS; Anita F. Das, PhD; et al. Editor's Note: Lefamulin—A New Antibiotic for Community-Acquired Pneumonia; Preeti N. Malani, MD, MSJ EDITOR'S NOTE Lefamulin—A New Antibiotic for Community-Acquired Pneumonia Preeti N. Malani, MD, MSJ

Trending CME articles from JN Learning™ Association Between Educational Attainment and Causes of Death Among White and Black US Adults, 2010-2017 | CME Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016 | CME Long-term Exposure to Ambient Air Pollution and Change in Emphysema and Lung Function | CME Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate in Patients With Uveitis | CME Effect of Combined Behavioral and Physical Therapy With Surgery vs Surgery Alone for Mixed Urinary Incontinence | CME JN Learning™ lets you earn AMA PRA Category 1 CME Credit™ from a source you trust. Explore all CME at JN Learning™